Medicine for treating hepatitis and cirrhosis ascites and its preparation method

Abstract

The invention relates to a traditional Chinese medicament for treating hepatitis and cirrhosis ascites which is prepared from the following raw materials (by weight portion): red ginseng 60-100 parts,white atractylodes rhizome 50-80 parts, borneol 30-50 parts, chicken's gizzard-skin 30-50 parts, red peony root 20-30 parts, blood clam shell 80-100 parts, centipede 40-50 parts, ligumaloes 20-30 parts, earthworm 80-100 parts and polyporus umbellatus 55-80 parts. The medicament is prepared through mixing, grinding into fines, sieving, and can be prepared into powders, tablets, capsules or pills.

Description

(1) Technical field [0001] The invention relates to a medicine for treating hepatitis and liver cirrhosis ascites. Specifically, the Chinese patent medicine is prepared from Chinese herbal medicine, and the invention also relates to a preparation method of the medicine. (2) Background technology [0002] Cirrhotic ascites is a common chronic progressive diffuse liver damage. In my country, it is mainly caused by viral hepatitis. The pathogenesis of cirrhotic ascites is complex, and its pathological features are degeneration, necrosis, and neogenesis of liver cells, accompanied by diffuse inflammation and hyperplasia of connective tissue, which eventually lead to structural damage of liver lobules and the formation of liver cirrhosis. At present, there is no specific treatment plan for the treatment of liver cirrhosis ascites. The most commonly used method is the operation method of pumping water from the abdominal cavity. However, this method has the disadvantages of easy...

AI Technical Summary

Problems solved by technology

At present, there is no specific treatment plan for the treatment of liver cirrhosis ascites. The most commonly used method is the operation method of pumping water from the abdominal cavity. However, this method has the disadvantages of easy infection, many complications, and pain for the patient. Moreover, the single treatment method of pumping ascites is a temporary solution. No permanent cure, high treatment cost and high mortality; Existing therapeutic drugs, such as Hugan Tablets, Yiganling, Liganlong and many other Chinese patent medicines and many western medicines, are mostly general antiviral or non-specific immune regulation Western medicine is effective in the early stage of diuresis, but its long-term curative effect is poor. The amount of medicine is large, and the treatment cost is high; Chinese patent ZL200610068814.4 records a Chinese patent medicine for the treatment of liver cirrhosis ascites, but it contains alum and rhinoceros horn powder, alum contains aluminum ions, which is not conducive to the recovery of liver function, and rhinoceros horn powder It is a rare and precious medicinal material, so it is extremely difficult to promote and implement this program

Therefore, the existing Chinese and Western medicines for the treatment of hepatitis and liver cirrhosis ascites cannot meet the needs of the majority of patients, and there is an urgent need for new medicines with good long-term curative effect and low treatment cost.